Dimerix Limited (DXB.AX)
AUD 0.73
(-3.31%)
AUD 0.73
(-3.31%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -17.07 Million AUD | -23.71% |
| 2023 | -13.8 Million AUD | -31.57% |
| 2022 | -10.49 Million AUD | -64.64% |
| 2021 | -6.37 Million AUD | -41.78% |
| 2020 | -4.49 Million AUD | -55.71% |
| 2019 | -2.88 Million AUD | 13.06% |
| 2018 | -3.31 Million AUD | -88.78% |
| 2017 | -1.75 Million AUD | 66.53% |
| 2016 | -5.25 Million AUD | -673.24% |
| 2015 | -679.53 Thousand AUD | -28.71% |
| 2014 | -527.97 Thousand AUD | -2.1% |
| 2013 | -517.09 Thousand AUD | -33.94% |
| 2012 | -386.07 Thousand AUD | -6925.85% |
| 2011 | 5656.00 AUD | 101.63% |
| 2010 | -347.76 Thousand AUD | 91.58% |
| 2009 | -4.12 Million AUD | -16.06% |
| 2008 | -3.55 Million AUD | -46.9% |
| 2007 | -2.42 Million AUD | 78.3% |
| 2006 | -11.16 Million AUD | -1773.29% |
| 2005 | -595.79 Thousand AUD | 11.86% |
| 2004 | -676 Thousand AUD | 28.54% |
| 2003 | -946 Thousand AUD | -32.12% |
| 2002 | -716 Thousand AUD | 82.95% |
| 2001 | -4.2 Million AUD | -713.95% |
| 2000 | -516 Thousand AUD | -179.84% |
| 1999 | 646.29 Thousand AUD | 8.05% |
| 1998 | 598.17 Thousand AUD | 527.27% |
| 1997 | -140 Thousand AUD | -13.36% |
| 1996 | -123.49 Thousand AUD | -0.4% |
| 1995 | -123 Thousand AUD | 10.22% |
| 1994 | -137 Thousand AUD | -110.77% |
| 1993 | -65 Thousand AUD | -6400.0% |
| 1992 | -1000.00 AUD | 99.71% |
| 1991 | -344 Thousand AUD | -189.08% |
| 1990 | -119 Thousand AUD | -232.22% |
| 1989 | 90 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -17.07 Million AUD | -23.71% |
| 2024 Q4 | -10.4 Million AUD | 0.0% |
| 2024 Q2 | -6.67 Million AUD | 0.0% |
| 2023 FY | -13.8 Million AUD | -31.57% |
| 2023 Q2 | -9.6 Million AUD | 0.0% |
| 2023 Q4 | -4.19 Million AUD | 0.0% |
| 2022 Q4 | -4.02 Million AUD | 0.0% |
| 2022 Q2 | -6.46 Million AUD | 0.0% |
| 2022 FY | -10.49 Million AUD | -64.64% |
| 2021 Q4 | -2.1 Million AUD | 0.0% |
| 2021 FY | -6.37 Million AUD | -41.78% |
| 2021 Q2 | -4.26 Million AUD | 0.0% |
| 2020 Q2 | -3.24 Million AUD | 0.0% |
| 2020 FY | -4.49 Million AUD | -55.71% |
| 2020 Q4 | -1.24 Million AUD | 0.0% |
| 2019 Q2 | -1.76 Million AUD | 0.0% |
| 2019 FY | -2.88 Million AUD | 13.06% |
| 2019 Q4 | -1.12 Million AUD | 0.0% |
| 2018 FY | -3.31 Million AUD | -88.78% |
| 2018 Q4 | -1.45 Million AUD | 0.0% |
| 2018 Q2 | -1.86 Million AUD | 0.0% |
| 2017 Q2 | -1.11 Million AUD | 0.0% |
| 2017 Q4 | -639.11 Thousand AUD | 0.0% |
| 2017 FY | -1.75 Million AUD | 66.53% |
| 2016 Q4 | -484.17 Thousand AUD | 0.0% |
| 2016 FY | -5.25 Million AUD | -673.24% |
| 2016 Q2 | -4.77 Million AUD | 0.0% |
| 2015 FY | -679.53 Thousand AUD | -28.71% |
| 2015 Q1 | -131.99 Thousand AUD | 0.0% |
| 2015 Q2 | -383.05 Thousand AUD | -190.21% |
| 2015 Q3 | -169.88 Thousand AUD | 55.65% |
| 2015 Q4 | -142.01 Thousand AUD | 16.41% |
| 2014 Q4 | - AUD | 100.0% |
| 2014 FY | -527.97 Thousand AUD | -2.1% |
| 2014 Q3 | -131.99 Thousand AUD | 0.0% |
| 2014 Q2 | -131.99 Thousand AUD | -2.1% |
| 2014 Q1 | -129.27 Thousand AUD | 0.0% |
| 2013 FY | -517.09 Thousand AUD | -33.94% |
| 2013 Q4 | - AUD | 100.0% |
| 2013 Q3 | -129.27 Thousand AUD | 0.0% |
| 2013 Q1 | -96.51 Thousand AUD | 0.0% |
| 2013 Q2 | -129.27 Thousand AUD | -33.94% |
| 2012 FY | -386.07 Thousand AUD | -6925.85% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q3 | -96.51 Thousand AUD | 0.0% |
| 2012 Q2 | -96.51 Thousand AUD | -6925.85% |
| 2012 Q1 | 1414.00 AUD | 0.0% |
| 2011 Q3 | 1414.00 AUD | 0.0% |
| 2011 Q2 | 1414.00 AUD | 101.63% |
| 2011 FY | 5656.00 AUD | 101.63% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q1 | -86.94 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 FY | -347.76 Thousand AUD | 91.58% |
| 2010 Q3 | -86.94 Thousand AUD | 0.0% |
| 2010 Q2 | -86.94 Thousand AUD | 91.58% |
| 2010 Q1 | -1.03 Million AUD | 0.0% |
| 2009 Q1 | -889.34 Thousand AUD | 0.0% |
| 2009 Q2 | -1.03 Million AUD | -16.06% |
| 2009 FY | -4.12 Million AUD | -16.06% |
| 2009 Q3 | -1.03 Million AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2008 Q1 | -605.41 Thousand AUD | 0.0% |
| 2008 Q2 | -889.34 Thousand AUD | -46.9% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 FY | -3.55 Million AUD | -46.9% |
| 2008 Q3 | -889.34 Thousand AUD | 0.0% |
| 2007 Q1 | -2.79 Million AUD | 0.0% |
| 2007 Q2 | -605.41 Thousand AUD | 78.3% |
| 2007 Q3 | -605.41 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 FY | -2.42 Million AUD | 78.3% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -2.79 Million AUD | -1773.29% |
| 2006 Q3 | -2.79 Million AUD | 0.0% |
| 2006 Q1 | -148.94 Thousand AUD | 0.0% |
| 2006 FY | -11.16 Million AUD | -1773.29% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q3 | -148.94 Thousand AUD | 0.0% |
| 2005 Q2 | -148.94 Thousand AUD | 11.88% |
| 2005 FY | -595.79 Thousand AUD | 11.86% |
| 2005 Q1 | -169.03 Thousand AUD | 0.0% |
| 2004 FY | -676 Thousand AUD | 28.54% |
| 2004 Q3 | -169.03 Thousand AUD | 0.0% |
| 2004 Q2 | -169.03 Thousand AUD | -1219.5% |
| 2004 Q1 | -12.81 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2003 Q3 | -12.81 Thousand AUD | 0.0% |
| 2003 Q1 | -184.91 Thousand AUD | 0.0% |
| 2003 FY | -946 Thousand AUD | -32.12% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q2 | -12.81 Thousand AUD | 93.07% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 FY | -716 Thousand AUD | 82.95% |
| 2002 Q1 | -1.08 Million AUD | 0.0% |
| 2002 Q2 | -184.91 Thousand AUD | 83.0% |
| 2002 Q3 | -184.91 Thousand AUD | 0.0% |
| 2001 FY | -4.2 Million AUD | -713.95% |
| 2001 Q1 | -129.23 Thousand AUD | 0.0% |
| 2001 Q2 | -1.08 Million AUD | -741.45% |
| 2001 Q3 | -1.08 Million AUD | 0.0% |
| 2001 Q4 | - AUD | 100.0% |
| 2000 FY | -516 Thousand AUD | -179.84% |
| 2000 Q4 | - AUD | 100.0% |
| 2000 Q3 | -129.23 Thousand AUD | 0.0% |
| 2000 Q1 | 161.57 Thousand AUD | 0.0% |
| 2000 Q2 | -129.23 Thousand AUD | -179.99% |
| 1999 Q2 | 161.57 Thousand AUD | 8.05% |
| 1999 FY | 646.29 Thousand AUD | 8.05% |
| 1999 Q4 | - AUD | -100.0% |
| 1999 Q3 | 161.57 Thousand AUD | 0.0% |
| 1999 Q1 | 149.54 Thousand AUD | 0.0% |
| 1998 Q4 | 149.54 Thousand AUD | 0.0% |
| 1998 Q3 | 149.54 Thousand AUD | 0.0% |
| 1998 Q2 | 149.54 Thousand AUD | 525.65% |
| 1998 FY | 598.17 Thousand AUD | 527.27% |
| 1998 Q1 | -35.13 Thousand AUD | 0.0% |
| 1997 Q3 | -35.13 Thousand AUD | 0.0% |
| 1997 Q1 | -30.87 Thousand AUD | 0.0% |
| 1997 Q4 | - AUD | 100.0% |
| 1997 FY | -140 Thousand AUD | -13.36% |
| 1997 Q2 | -35.13 Thousand AUD | -13.79% |
| 1996 Q3 | -30.87 Thousand AUD | 0.0% |
| 1996 Q1 | -30.75 Thousand AUD | 0.0% |
| 1996 Q4 | -30.87 Thousand AUD | 0.0% |
| 1996 FY | -123.49 Thousand AUD | -0.4% |
| 1996 Q2 | -30.87 Thousand AUD | -0.4% |
| 1995 Q3 | -30.75 Thousand AUD | 0.0% |
| 1995 Q4 | -30.75 Thousand AUD | 0.0% |
| 1995 Q2 | -30.75 Thousand AUD | 10.22% |
| 1995 Q1 | -34.25 Thousand AUD | 0.0% |
| 1995 FY | -123 Thousand AUD | 10.22% |
| 1994 Q2 | -34.25 Thousand AUD | -110.77% |
| 1994 Q1 | -16.25 Thousand AUD | 0.0% |
| 1994 Q4 | -34.25 Thousand AUD | 0.0% |
| 1994 FY | -137 Thousand AUD | -110.77% |
| 1994 Q3 | -34.25 Thousand AUD | 0.0% |
| 1993 Q2 | -16.25 Thousand AUD | -6400.0% |
| 1993 Q4 | -16.25 Thousand AUD | 0.0% |
| 1993 FY | -65 Thousand AUD | -6400.0% |
| 1993 Q3 | -16.25 Thousand AUD | 0.0% |
| 1993 Q1 | -250.00 AUD | 0.0% |
| 1992 FY | -1000.00 AUD | 99.71% |
| 1992 Q1 | -86 Thousand AUD | 0.0% |
| 1992 Q2 | -250.00 AUD | 99.71% |
| 1992 Q4 | -250.00 AUD | 0.0% |
| 1992 Q3 | -250.00 AUD | 0.0% |
| 1991 Q3 | -86 Thousand AUD | 0.0% |
| 1991 Q4 | -86 Thousand AUD | 0.0% |
| 1991 Q1 | -29.75 Thousand AUD | 0.0% |
| 1991 Q2 | -86 Thousand AUD | -189.08% |
| 1991 FY | -344 Thousand AUD | -189.08% |
| 1990 Q2 | -29.75 Thousand AUD | -232.22% |
| 1990 Q3 | -29.75 Thousand AUD | 0.0% |
| 1990 Q4 | -29.75 Thousand AUD | 0.0% |
| 1990 FY | -119 Thousand AUD | -232.22% |
| 1990 Q1 | 22.5 Thousand AUD | 0.0% |
| 1989 Q2 | 22.5 Thousand AUD | 0.0% |
| 1989 FY | 90 Thousand AUD | 0.0% |
| 1989 Q3 | 22.5 Thousand AUD | 0.0% |
| 1989 Q4 | 22.5 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -217.306% |
| Acrux Limited | -5.8 Million AUD | -194.398% |
| Actinogen Medical Limited | -13.04 Million AUD | -30.901% |
| AnteoTech Limited | -8.88 Million AUD | -92.276% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -211.618% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -95.232% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -1076.584% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 10.711% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -279.155% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -396.865% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -608.751% |
| Biome Australia Limited | -1.67 Million AUD | -922.336% |
| Biotron Limited | -3.43 Million AUD | -396.871% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | -23.111% |
| BTC Health Limited | 1.05 Million AUD | 1718.051% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -36.275% |
| CSL Limited | 2.64 Billion AUD | 100.646% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 59.657% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 147.915% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -75.224% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 345.174% |
| Hexima Limited | -933.87 Thousand AUD | -1728.416% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -496.131% |
| Immuron Limited | -6.93 Million AUD | -146.147% |
| Immutep Limited | -39.89 Million AUD | 57.201% |
| Imugene Limited | -149.68 Million AUD | 88.592% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -940.016% |
| Memphasys Limited | -4.44 Million AUD | -284.399% |
| Nanollose Limited | -1.15 Million AUD | -1376.377% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 110.87% |
| Noxopharm Limited | -3.57 Million AUD | -377.209% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 5366.674% |
| Nyrada Inc. | -1.38 Million AUD | -1131.767% |
| Orthocell Limited | -7.18 Million AUD | -137.783% |
| PharmAust Limited | -9.03 Million AUD | -89.044% |
| Patrys Limited | -3.53 Million AUD | -382.463% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 70.888% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -167.793% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -107.271% |
| PYC Therapeutics Limited | -37.72 Million AUD | 54.739% |
| Race Oncology Limited | -13.81 Million AUD | -23.559% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 64.389% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 3.321% |
| Starpharma Holdings Limited | -8.16 Million AUD | -109.125% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 427.674% |
| Tissue Repair Ltd | -4.13 Million AUD | -312.631% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 53.307% |